164 related articles for article (PubMed ID: 24174288)
1. Postmenopausal estrogen therapy and risk of gallstone disease: a population-based case-control study.
Simonsen MH; Erichsen R; Frøslev T; Rungby J; Sørensen HT
Drug Saf; 2013 Dec; 36(12):1189-97. PubMed ID: 24174288
[TBL] [Abstract][Full Text] [Related]
2. Long-term statin use and the risk of gallstone disease: A population-based case-control study.
Erichsen R; Frøslev T; Lash TL; Pedersen L; Sørensen HT
Am J Epidemiol; 2011 Jan; 173(2):162-70. PubMed ID: 21084557
[TBL] [Abstract][Full Text] [Related]
3. Postmenopausal estrogen-containing hormone therapy and the risk of breast cancer.
Jick SS; Hagberg KW; Kaye JA; Jick H
Obstet Gynecol; 2009 Jan; 113(1):74-80. PubMed ID: 19104362
[TBL] [Abstract][Full Text] [Related]
4. Endometrial carcinoma risks among menopausal estrogen plus progestin and unopposed estrogen users in a cohort of postmenopausal women.
Lacey JV; Brinton LA; Lubin JH; Sherman ME; Schatzkin A; Schairer C
Cancer Epidemiol Biomarkers Prev; 2005 Jul; 14(7):1724-31. PubMed ID: 16030108
[TBL] [Abstract][Full Text] [Related]
5. Endometrial cancer risk in estrogen users after switching to estrogen-progestin therapy.
Chubak J; Doherty JA; Cushing-Haugen KL; Voigt LF; Saltzman BS; Hill DA; Beresford SA; Weiss NS
Cancer Causes Control; 2007 Nov; 18(9):1001-7. PubMed ID: 17653829
[TBL] [Abstract][Full Text] [Related]
6. Postmenopausal hormone replacement therapy and risk of acute pancreatitis: a population-based case-control study.
Tetsche MS; Jacobsen J; Nørgaard M; Baron JA; Sørensen HT
Am J Gastroenterol; 2007 Feb; 102(2):275-8. PubMed ID: 17311649
[TBL] [Abstract][Full Text] [Related]
7. Estrogen-progestin replacement therapy and endometrial cancer.
Pike MC; Peters RK; Cozen W; Probst-Hensch NM; Felix JC; Wan PC; Mack TM
J Natl Cancer Inst; 1997 Aug; 89(15):1110-6. PubMed ID: 9262248
[TBL] [Abstract][Full Text] [Related]
8. Esterified estrogens and conjugated equine estrogens and the risk of venous thrombosis.
Smith NL; Heckbert SR; Lemaitre RN; Reiner AP; Lumley T; Weiss NS; Larson EB; Rosendaal FR; Psaty BM
JAMA; 2004 Oct; 292(13):1581-7. PubMed ID: 15467060
[TBL] [Abstract][Full Text] [Related]
9. Statin use and risk of gallstone disease followed by cholecystectomy.
Bodmer M; Brauchli YB; Krähenbühl S; Jick SS; Meier CR
JAMA; 2009 Nov; 302(18):2001-7. PubMed ID: 19903921
[TBL] [Abstract][Full Text] [Related]
10. Postmenopausal estrogen and progestin use in relation to breast cancer risk.
Newcomb PA; Titus-Ernstoff L; Egan KM; Trentham-Dietz A; Baron JA; Storer BE; Willett WC; Stampfer MJ
Cancer Epidemiol Biomarkers Prev; 2002 Jul; 11(7):593-600. PubMed ID: 12101105
[TBL] [Abstract][Full Text] [Related]
11. Effect of reproductive factors and postmenopausal hormone use on the risk of Parkinson disease.
Popat RA; Van Den Eeden SK; Tanner CM; McGuire V; Bernstein AL; Bloch DA; Leimpeter A; Nelson LM
Neurology; 2005 Aug; 65(3):383-90. PubMed ID: 16087902
[TBL] [Abstract][Full Text] [Related]
12. Statin use and the risk of gallstone disease: a population-based case-control study.
Chiu HF; Chen CC; Kuo HW; Lee IM; Wu TN; Yang CY
Expert Opin Drug Saf; 2012 May; 11(3):369-74. PubMed ID: 22243480
[TBL] [Abstract][Full Text] [Related]
13. Parity, menopausal hormone therapy, and risk of ovarian granulosa cell tumor - A population-based case-control study.
Bryk S; Katuwal S; Haltia UM; Tapper J; Tapanainen JS; Pukkala E
Gynecol Oncol; 2021 Dec; 163(3):593-597. PubMed ID: 34598830
[TBL] [Abstract][Full Text] [Related]
14. Risk of venous thromboembolism associated with local and systemic use of hormone therapy in peri- and postmenopausal women and in relation to type and route of administration.
Bergendal A; Kieler H; Sundström A; Hirschberg AL; Kocoska-Maras L
Menopause; 2016 Jun; 23(6):593-9. PubMed ID: 27023862
[TBL] [Abstract][Full Text] [Related]
15. Statin Use and Risk of Atrial Fibrillation or Flutter: A Population-based Case-Control Study.
Veronese G; Montomoli J; Schmidt M; Horváth-Puhó E; Sørensen HT
Am J Ther; 2015; 22(3):186-94. PubMed ID: 23567792
[TBL] [Abstract][Full Text] [Related]
16. Estrogen and estrogen-progestin replacement therapy and risk of postmenopausal breast cancer in Canada.
Kirsh V; Kreiger N
Cancer Causes Control; 2002 Aug; 13(6):583-90. PubMed ID: 12195648
[TBL] [Abstract][Full Text] [Related]
17. Effect of hormone replacement therapy on breast cancer risk: estrogen versus estrogen plus progestin.
Ross RK; Paganini-Hill A; Wan PC; Pike MC
J Natl Cancer Inst; 2000 Feb; 92(4):328-32. PubMed ID: 10675382
[TBL] [Abstract][Full Text] [Related]
18. Estrogen replacement therapy and ovarian cancer mortality in a large prospective study of US women.
Rodriguez C; Patel AV; Calle EE; Jacob EJ; Thun MJ
JAMA; 2001 Mar; 285(11):1460-5. PubMed ID: 11255422
[TBL] [Abstract][Full Text] [Related]
19. Gender and gallstone disease.
Novacek G
Wien Med Wochenschr; 2006 Oct; 156(19-20):527-33. PubMed ID: 17103289
[TBL] [Abstract][Full Text] [Related]
20. Breast cancer risk with postmenopausal hormonal treatment.
Collins JA; Blake JM; Crosignani PG
Hum Reprod Update; 2005; 11(6):545-60. PubMed ID: 16150813
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
